Hedge Fund - Great Point Partners
Urogen Pharma Ltd. (URGN)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q4 (2023-12-31) | $39,308,175 | 6.69% | 2,620,545 | $12.98 |
2 | 2023 - Q3 (2023-09-30) | $36,713,835 | 6.68% | 2,620,545 | $16.05 |
3 | 2023 - Q2 (2023-06-30) | $0 | 0% | 0 | $11.03 |
4 | 2023 - Q1 (2023-03-31) | $362,411 | 0.07% | 39,222 | $9.20 |
5 | 2022 - Q4 (2022-12-31) | $4,967,200 | 0.97% | 560,000 | $9.47 |
6 | 2022 - Q3 (2022-09-30) | $7,267,000 | 1.74% | 873,424 | $8.27 |
7 | 2022 - Q2 (2022-06-30) | $7,153,000 | 1.71% | 873,424 | $6.87 |
8 | 2022 - Q1 (2022-03-31) | $7,608,000 | 1.83% | 873,424 | $7.80 |
9 | 2021 - Q4 (2021-12-31) | $8,306,000 | 1.84% | 873,424 | $14.10 |
10 | 2021 - Q3 (2021-09-30) | $12,615,000 | 2.93% | 750,000 | $15.85 |
The displayed share prices are average quarterly stock market prices.